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  Abstract 
Background: Transdiagnostic cognitive behavioral therapy for emotional disorders 
has proven to be effective. However, current transdiagnostic treatment protocols 
address only the regulation of negative affectivity, and they do not include treatment 
components to more directly target the regulation of positive affectivity. 
Aims: To evaluate the preliminary efficacy and acceptability of a transdiagnostic 
treatment protocol for emotional disorders that includes, as an innovative feature, a 
specific treatment component to directly up-regulate positive affectivity based on 
positive psychology interventions.   
Method: Twenty-four participants were randomized to either a transdiagnostic 
treatment protocol (N=12) or a transdiagnostic treatment protocol with an additional 
component designed to regulate positive affectivity (n=12). Participants completed 
measures of anxiety, depression, positive and negative affectivity, and quality of life, 
as well as treatment acceptability at pre- and post-treatment and at the 3-month 
follow-up. 
Results: Both interventions led to improvements in all measures at post-treatment, 
and these outcomes were maintained at the 3-month follow-up, with large effect 
sizes for all measures. The effect sizes for positive affect were larger in the condition 
that included the component to up-regulate positive affectivity. Attrition rate was 
low and both treatment protocols were well-accepted by participants. 
Conclusions: The results obtained in this study indicate the feasibility of testing the 
treatment protocol in a larger, randomized, controlled trial, and they suggest the 
potential of including treatment components for directly up-regulating positive 
affectivity in future research on transdiagnostic treatment protocols for emotional 
disorders.  
Keywords: positive affectivity; transdiagnostic; cognitive behavioral therapy; 
emotional disorders; emotion regulation 
 
 
 
 
 3		
Introduction 
Emotional disorders (ED) (depression and anxiety disorders) are highly prevalent mental 
disorders (Kessler et al., 2005; Wittchen et al., 2010) and one of the main causes of 
disability worldwide (Kazdin, & Blase, 2011; McLean, Asnaani, Litz, & Hofmann, 2011). 
Currently, there is extensive evidence showing the efficacy and effectiveness of disorder-
specific cognitive-behavior therapy (CBT) for several ED, including major depression 
disorder (MDD) (Cuijpers, Smit, Bohlmeijer, Hollon, & Andersson, 2010; Hollon, & 
Ponniah, 2010), obsessive-compulsive disorder (OCD) (McKay et al., 2015), and different 
anxiety disorders, such as generalized anxiety disorder (GAD), panic disorder (PD), 
agoraphobia (AG), and social anxiety disorder (SAD) (Antony, & Stein, 2009; Barlow, 
2002; Nathan, & Gorman, 2007; Olatunji, Cisler, & Deacon, 2010). However, high 
comorbidity rates among ED (Kessler et al., 2005) have led some researchers to shift the 
focus to treatment strategies (referred to as transdiagnostic treatments) that might be more 
widely effective across these diverse mental health problems (Clark, & Taylor, 2009).   
To date, there is evidence showing the efficacy of transdiagnostic treatments for 
anxiety disorders (Reinholt, & Krogh, 2014), and for mixed depression and anxiety 
disorders (Newby, McKinnon, Kuiken, Gilbody, & Dalgleish, 2015; Păsărelu, Andersson, 
Nordgren, Dobrean, 2016). An important line of research within the transdiagnostic 
treatment of ED was initiated by D. H. Barlow (Barlow, Allen, & Choate, 2004). Barlow’s 
theory of triple vulnerability emphasizes the common underlying vulnerabilities in ED and 
helps to explain the comorbidity among these diverse conditions (Brown, & Barlow, 
2009). A central aspect within this theoretical perspective is the role of emotion regulation 
in ED (Barlow et al., 2004). Emotion regulation has been defined as the attempt to 
influence the types of emotions people experience, when they experience these emotions, 
and how these emotions are expressed and experienced (Gross, 1998), with regard to either 
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negative or positive emotions. Moreover, people can use emotion regulation to up-regulate 
(increase and/or maintain) or down-regulate (decrease) emotions (Gross, 1998). 
Difficulties in the regulation of both negative and positive emotions have emerged in 
research as a common feature in depression and anxiety disorders (Carl, Soskin, Kerns, & 
Barlow, 2013; Hofmann, Sawyer, Fang, & Asnaani, 2012). The core of these emotion 
regulation difficulties has been identified as neuroticism or negative affect (N/NA) 
(Brown, & Barlow, 2009; Barlow, Sauer-Zavala, Carl, Bullis, & Ellard, 2014). However, 
these deficits have also been associated with low extraversion/positive affect (E/PA). For 
instance, the association between low PA and several ED, such as unipolar depression 
(Clark, & Watson, 1991), SAD (Brown, Chorpita, & Barlow, 1998) and AG (Rosellini, 
Lawrence, Meyer, & Brown, 2010), has been shown in previous research. Additionally, 
there is evidence indicating that most individuals with anxiety and mood disorders show 
low levels of PA (Kotov, Gámez, Schmidt, & Watson, 2010). Regarding depression, 
literature has suggested that there is a link between the maladaptive strategies used by 
depressed patients to regulate PA and depression symptoms (Gilbert, 2012; Gilbert, Nolen-
Noeksema, & Gruber, 2013; Werner-Seidler, Banks, Dunn, & Moulds, 2013), and that 
deficits in PA regulation are associated with a worse depression prognosis (Shankman, 
Nelson, Harrow, & Faull, 2011). Finally, a review focused on PA regulation in ED 
concluded that there are transdiagnostic disturbances in the strategies used to regulate 
positive emotions that may account for low levels of PA in depression and several anxiety 
disorders such as GAD, AG, PD, SAD, and OCD (Carl et al., 2013).    
The regulation of negative emotions in transdiagnostic models for ED such as the 
Unified Protocol (UP) has received a great deal of attention in research (Barlow et al., 
2013; Ellard, Fairholme, Boisseau, Farchione, & Barlow, 2010). This protocol focuses on 
four essential aspects that have the general purpose of down-regulating NA: increasing 
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present-focused emotional awareness, addressing maladaptive emotional avoidance 
behavior patterns, promoting cognitive flexibility, and facilitating interoceptive and 
situational exposure. However, although Barlow highlighted the role of low PA in the 
onset and maintenance of ED (Barlow et al., 2004; Brown, & Barlow, 2009), the main 
objective of the treatment components in the UP is to train patients in NA regulation, and 
less attention is paid to the inclusion of treatment components to directly target PA 
regulation. This is also the case in other empirically evaluated transdiagnostic treatments 
for anxiety disorders (e. g., Norton, 2012; Titov, Andrews, Johnston, Robinson, & Spence, 
2010) and mixed anxiety and depression (e. g., Titov et al., 2011; Berger, Boettcher, & 
Caspar, 2013).   
PA regulation may have important implications in treatment because high PA is 
associated with better physical and psychological health, healthier lifestyles, and better 
general functioning (Cohen, & Pressman, 2006; Fredrickson, 2001; Livingstone, & 
Srivastava, 2012; Pressman, & Cohen, 2005; Quoidbach, Berry, Hansenne, & Mikolajczac, 
2010; Tugade, & Fredrickson, 2007). Moreover, the importance of fostering PA, in 
addition to reducing NA, to improve treatment outcomes in depression and anxiety 
disorders has been highlighted in the literature (Carl et al., 2013) because high PA seems to 
promote general well-being, prevent relapses, and produce resilience (Dunn, 2012; 
Tugade, & Fredrickson, 2007; Wood, & Joseph, 2010).  
Positive psychology interventions (PPIs) mainly focus on enhancing positive 
emotional functioning and wellbeing (Schueller, Kashdan, & Parks, 2014). Schueller & 
Parks (2014) distinguished five categories under the umbrella of PPIs: a) savoring 
experiences and sensations; b) cultivating and expressing gratitude; c) engaging in kind 
actions; d) promoting positive relationship processes; and e) pursuing hope and meaning. 
Meta-analyses have shown that these interventions  are effective for enhancing wellbeing 
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and reducing depressive symptoms in both the general population and in individuals with a 
variety of psychosocial problems (Bolier et al. 2013; Schueller, & Parks, 2014; Sin & 
Lyubomirsky, 2009; Weiss et al., 2016). The addition of PPIs to existing CBT 
interventions (e.g. transdiagnostic interventions) could help to strengthen their effect on 
PA, leading to greater and more lasting effects on positive emotional functioning and 
wellbeing. Taylor, Lyubomirsky, & Stein (2017) recently studied the efficacy of a 
transdiagnostic intervention based on PPIs for mixed anxiety and depression, reporting 
significant gains in PA and secondary gains in NA, depression, and anxiety symptoms. 
However, this study differs from ours in that it does not include strategies for down-
regulating NA. In regard to this point, the literature has mainly focused on studying the 
impact of PPIs on depressive symptoms rather than anxiety (see Bolier et al., 2013; Sin & 
Lyubomirsky, 2009; Weiss et al., 2016). However, research suggests that anxiety disorders 
may be also appropriate targets for treatments based on PPIs. For instance, AG or SAD 
have been shown to be characterized by low levels of PA (Brown et al., 1998; Rosellini et 
al., 2010). Another reason why anxiety disorders may benefit from PPIs is that anxious 
individuals often engage in strategies that lead to the avoidance of positive experiences and 
emotions, as outlined in the review by Carl et al. (2013).  Accordingly, well-being may be 
increased in these patients by training them in strategies to up-regulate PA.  
Another intervention for depression that can help to promote wellbeing is 
behavioral activation (Lejuez, Hopko, & Hopko, 2001; Lewinsohn, 1974). From the 
approach of behavioral activation, depressive symptoms are deemed as the result of 
decreased levels of activity that lead to a loss of positive reinforcement (Lewinsohn, 1974). 
The efficacy of behavioral activation in improving wellbeing has been shown in previous 
research in both depressed (Mazzucchelli, Kane, & Rees, 2009). and non-depressed 
populations (Mazzucchelli, Kane, & Rees, 2010). Thus, the ability to increase wellbeing 
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and positive emotion functioning may be strengthen by including behavioral activation 
procedures in interventions, at least for individuals with depression.  
Taking all this into consideration, an important treatment goal from a 
transdiagnostic treatment approach would be to increase PA while decreasing NA.  
 
Aims 
We developed a transdiagnostic protocol (TP) for ED based on the UP (Barlow et al., 
(2011) and another version of this protocol that also includes a specific component mainly 
based on PPIs to directly address PA regulation (TP+PA).  
Both protocols were tested using a two-armed randomized pilot study. The aim was 
to assess the differential effect of both interventions on measures of depression, anxiety 
and quality of life, and on PA and NA. Another goal was to evaluate treatment retention 
and the acceptability of both interventions by participants. It was hypothesized that: a) both 
interventions would result in significant improvements on all clinical measures at post-
treatment, and these results would be maintained in the short-term (3-month follow-up); b) 
the TP+PA would significantly outperform the TP group on PA measures; c) acceptability 
would be high in both conditions, with no statistical differences between conditions. 
 
Method 
Procedure  
Participants were recruited from individuals seeking treatment at the Emotional Disorders 
Clinic (Castellon, Spain). After an initial screening assessment that included the 
administration of a diagnostic interview, participants who met the inclusion criteria were 
asked to sign a consent form and then randomly assigned to either the TP group or the 
TP+PA group. Block randomization in blocks of four was performed using a computer-
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generated random number sequence. Once participants had been assigned to one of the 
conditions, they completed pre-treatment primary and secondary outcome measures (self-
reported questionnaires). In both groups, the interventions started immediately after pre-
treatment assessment. After each treatment session, participants were given a patient 
treatment handbook and asked to do homework tasks in order to review the specific 
contents and practice the proposed strategies and skills learned in each session. After 
completing the treatment protocols, a diagnostic interview and primary and secondary 
outcome measures were administered to obtain post-treatment data. The assessment 
instruments were also applied at the 3-month follow-up. All assessments (i.e. diagnostic 
interviews) were conducted by independent assessors who were blind to the participants’ 
allocation.  
The study was registered in Clinicaltrials.gov (https://clinicaltrials.gov/) as 
NCT02790398 and approved by the Ethics Committee of Universitat Jaume I (Castellon, 
Spain). 
 
Participants 
Twenty-six participants met the inclusion criteria. In the TP+PA group, one participant 
dropped out after 11 treatment sessions, stating that she had no time to dedicate to the 
therapy.  In the TP group, one participant dropped out after session 5 because she had to 
move to another city. These participants were excluded from the analyses; therefore, the 
final sample included 24 participants (see flow of participants in Figure 1).  
 
[Insert Figure 1 about here] 
 
 9		
The baseline characteristics of the sample are described in Table 1. Inclusion 
criteria were as follows: a) being 18 years old or older; b) meeting the DSM-IV (APA, 
2000) diagnostic criteria for ED, which included major depression disorder (MDD), 
dysthymic disorder (DD), generalized anxiety disorder (GAD), social anxiety disorder 
(SAD), panic disorder (PD), agoraphobia (AG), anxiety disorder not otherwise specified 
(ADNOS), (unipolar) mood disorder not otherwise specified (MDNOS), and obsessive-
compulsive disorder (OCD); and c) ability to understand and read Spanish. Exclusion 
criteria included: a) schizophrenia, bipolar disorder, or alcohol and/or substance 
dependence disorder; b) high risk of suicide; c) receiving another psychological treatment 
during the study; and d) in the case of receiving pharmacological treatment, an increase 
and/or change in this treatment during the study period (a decrease in pharmacological 
treatment was accepted).  
 
[Insert table about 1 here] 
 
In the TP group, four participants were taking pharmacological treatment at the 
time of enrolment. All of them were taking benzodiazepines. In the TP+PA group, three 
participants were receiving pharmacological treatment at the time of enrolment. Two of 
them were taking benzodiazepines, and one was taking antidepressants in addition to 
benzodiazepines. All participants in both conditions decreased the dosage or stopped 
taking medication during the study. At post-treatment and at the 3-month follow-up, none 
of the participants were receiving pharmacological treatment.  
 
Measures 
Diagnostic measure 
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Mini International Neuropsychiatric Interview Version 5.0.0 (MINI) (Sheehan et al., 1998). 
This is a short, structured, diagnostic psychiatric interview that yields key DSM-IV and 
ICD-10 diagnoses. The MINI can be administered in a short period of time, and clinical 
interviewers only need brief training. The MINI has been translated into Spanish and 
validated (Ferrando, Bobes, Gibert, & Lecrubier, 1997). 
 
Self-administered questionnaires 
Overall Anxiety Severity and Impairment Scale (OASIS) (Norman et al., 2011). This is a 5-
item scale, rated from 0 to 4, that evaluates the frequency, severity, and work, social, 
academic, and everyday life impairment caused by anxiety symptoms in the past week. 
The internal consistency of the OASIS has been found to be good (α = .80). The scale has 
also shown good test-retest reliability (k= .82) and convergent validity. We used the 
Spanish version of the instrument, which also showed adequate psychometric properties 
(Mira et al., 2015). In the present study, the Cronbach’s alpha for the OASIS was α = .81. 
Beck Depression Inventory (BDI-II) (Beck, Steer, & Brown, 1990). It is one of the 
most widely-used questionnaires to evaluate depression severity in pharmacological and 
psychotherapy trials. It consists of 21 items about the different symptoms characterizing 
major depression disorder, added together to obtain the total score, which can yield a 
maximum of 63 points. The instrument has shown good internal consistency (α = 0.76 to 
0.95). The Spanish version of this instrument has also shown high internal consistency (α = 
0.87) in both general and clinical populations (α = .89) (Sanz, Navarro, & Vázquez, 2003). 
In the present study, the Cronbach’s alpha for the BDI-II was α = .92. 
Positive and Negative Affect Scale (PANAS) (Watson, Clark, & Tellegen, 1988). 
The PANAS consists of 20 items that evaluate two independent dimensions: positive affect 
(PA) and negative affect (NA). It contains 10 descriptors evaluating PA (e. g., 
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“enthusiastic”, “inspired”, “proud”) and 10 others assessing NA (e. g. “scared”, “irritable”, 
“guilty”). The range for each scale (10 items on each) is from 10 to 50 and the patient has 
to answer how he/she usually feels regarding each of these emotions. The scale showed 
excellent internal consistency (α between .84 and .90) and convergent and discriminant 
validity. The Spanish version has demonstrated high internal consistency (α = 0.89 and 
0.91 for PA and NA in women, respectively, and α = 0.87 and 0.89 for PA and NA in men, 
respectively) in college students (Sandín et al., 1999). In the present study, the Cronbach’s 
alpha for the PANAS PA was α = .94, and for the PANAS NA, α = .88. 
The Quality of Life Inventory (QLI) (Mezzich, Cohen, & Ruiperez, 1996). This is a 
brief self-report questionnaire that assesses perceived quality of life in different life-related 
areas. The questionnaire includes 10 items, rated on a scale from one to 10, that assess 
physical well-being, psychological well-being, self-care and independent functioning, 
occupational functioning, interpersonal functioning, social emotional support, community 
and services support, personal fulfillment, spiritual fulfillment, and overall quality of life. 
The QLI has shown excellent internal consistency (between .90 and .92), test-retest 
reliability (.87) and discriminant validity. The Spanish validation of the QLI (Mezzich et 
al., 2000) has also demonstrated good test-retest reliability (α = .89) and discriminant 
validity. In the present study, the Cronbach’s alpha for the QLI was α = .87. 
 
Acceptability of treatment 
Expectations and opinion of treatment Scale. These questionnaires are adapted from 
Borkovec and Nau (1972). Each scale is made up of 5 items, rated on a scale from 0 
(nothing at all) to 10 (completely), that cover how logical the treatment seems to be (“How 
logical do you think this treatment is?”), to what extent it could satisfy the patient (“How 
satisfied are you with the treatment?”), whether it could be recommended to a person with 
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the same problem (“To what extent do you feel confident recommending this treatment to a 
friend who has the same problems?”), whether it could be used to treat other psychological 
problems (“To what extent do you think this treatment could be useful in treating other 
psychological problems?”), and its usefulness for the patient’s problem (“To what extent 
do you think this treatment will be/was helpful to you?”). The expectation scale is applied 
once the treatment rationale has been explained. Its aim is to measure subjective patient 
expectations about this treatment. The opinion scale is administered when the patient has 
completed the treatment, and its aim is to assess satisfaction with this treatment. Our group 
has used this questionnaire in several research studies (Botella et al., 2007, 2009). 
 
Interventions 
Transdiagnostic protocol (TP) 
We developed a transdiagnostic protocol for the treatment of ED, adapted from the UP 
(Barlow et al., 2011) and some of the strategies for emotion regulation from dialectical 
behavior therapy (DBT) (Linehan, 2003). All the strategies and techniques from the 
original protocols (UP) have been translated into Spanish, and the contents (e.g. clinical 
examples) adjusted for cultural differences. The addition of some strategies from DBT (i.e. 
mindfulness “what” and “how” skills) was considered important because emotion 
regulation difficulties have been shown to be a key transdiagnostic factor across distinct 
ED (Campbell-Sills, Barlow, Brown, & Hofmann, 2006; Cisler, Olatunji, Feldner, & 
Forsyth, 2010) and an important treatment target (Neacsiu, Eberle, Kramer, Wiesmann, & 
Linehan, 2014). The main differences between the UP and the protocol developed for the 
present study (TP) are shown in Table 2.  
 
[Insert table 2 here] 
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The TP is a manualized, structured treatment protocol made up of 12 treatment 
modules with the general aim of regulating NA (Botella, García-Palacios, Baños, 
unpublished manuscript). These modules are usually administered in 12 to 15 weekly face-
to-face sessions (maximum of 18) lasting 60 minutes. Modules 1 to 11 contain strategies 
for the regulation of NA with the following main therapeutic components from the UP: a) 
present-focused emotional awareness, b) cognitive flexibility, c) emotion avoidance and 
emotion-driven behaviors, d) awareness and tolerance of physical sensations, and e) 
interoceptive and situation-based emotion exposure. Modules 1 to 11 are preceded by three 
modules (module 1 is an introduction to treatment, module 2 is focused on motivation 
enhancement, and module 3 provides psychoeducation about emotions) and followed by a 
relapse prevention module (module 12). The treatment protocol includes one patient 
handbook and one therapist handbook for each treatment session. In this condition, 
participants completed a mean of 13.25 sessions (SD = .75) (range 12-14). Modules 1 to 12 
are described below: 
- Module 1. Introduction to treatment: Provides a framework about the role of 
emotion regulation in emotional disorders. A brief description of the program 
modules is also presented, as well as videos with examples of people suffering 
from different emotional disorders. 
- Module 2. Motivation for change and goal setting: The aims are to analyze the 
advantages and disadvantages of changing, emphasize the importance of being 
motivated, and highlight the importance of establishing significant life goals. 
- Module 3. Understanding the role of emotions: Provides psychoeducation about the 
adaptive roles and functions of emotions and trains the patient in tracking of 
emotional experiences using the three-component model of emotions. 
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- Module 4. Non-judgmental emotional awareness and acceptance of emotional 
experiences: This module aims to train the patient in non-judgmental emotional 
awareness (i.e. mindfulness “what” and “how” skills) and in the acceptance of 
emotional experiences and its importance in the treatment.  
- Module 5. Practicing present-focused awareness: The objective is to continue to 
learn about the acceptance of emotional experiences and increase awareness of 
physical sensations, thoughts, emotions and daily activities. 
- Module 6. Learning to be flexible: It focuses on the importance of maladaptive 
ways of thinking (i.e. thinking traps) in the maintenance of emotional disorders, 
and on learning how to identify them. 
- Module 7. Practicing cognitive flexibility: This module aims to teach the patients 
how maladaptive ways of thinking can be modified (i.e. cognitive reappraisal). It 
also provides information about intrusive thoughts and how to deal with them. 
- Module 8. Emotional avoidance: This module aims to teach the patients to identify 
the emotion avoidance strategies that contribute to the maintenance of ED. 
- Module 9. Emotion-Driven Behaviors: The aim is for patients to learn the concept 
of emotion-driven behaviors (EDB) and replace their own maladaptive EDB with 
other more adaptive behaviors. 
- Module 10. Accepting and facing physical sensations: The objectives are to teach 
the patients the role of physical sensations in their emotional response and train 
them in interoceptive exposure, in order to increase tolerance and promote 
habituation to physical sensations. 
- Module 11. Facing emotions in the contexts in which they occur: The purpose is 
the construction of exposure hierarchies to help the patients begin to face the 
avoided situations that contribute to the maintenance of the problem. 
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- Module 12. Relapse prevention: This module aims to review the strategies learned 
throughout the program, schedule the future practice of the learned strategies, and 
teach the patient how to identify and cope with future high- risk situations. 
 
Transdiagnostic protocol + Positive affectivity regulation component (TP+PA) 
This intervention comprises 16 modules generally delivered in 16 to 19 treatment sessions 
(maximum of 22).  As in the TP, this protocol also includes one patient handbook and one 
therapist handbook for each module. The structure of this protocol is as follows: a) 
modules 1 to 11 are the same modules as in the TP; b) modules 12 to 15 constitute a 
treatment component aimed at the regulation of PA (i.e. enhancement and maintenance of 
PA); c) module 16 is focused on relapse prevention. In this condition, participants 
completed a mean of 17.42 sessions (SD = 1.08) (range 16-19). Modules 12 to 15 (PA 
regulation component) are depicted below: 
- Module 12: Learning to move on. This module is focused on the role of behavioral 
activation, teaching the patient the importance of ‘moving on’. Behavioral 
activation is trained using a diary of daily activities. In order to complete this diary, 
the patient is provided with monitoring sheets with a scale ranging from 0 to 10 to 
score both the level of satisfaction with the activities the patient is involved in 
during the day and to what extent they are linked to his/her personal goals and 
values. The practice of this exercise is intended to help the patient realize the 
positive relationship between meaningful activities and mood in order to promote 
behavioral activation (Lejuez et al., 2001). 
- Module 13: Learning to enjoy. This module consists of psychoeducation about the 
role of positive emotions in life and how to generate and maintain them (e. g. using 
savoring strategies) (Bryant, 2007). The strategies included in this module are 
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consistent with Fredrickson’s Broaden-and-Build Theory (Fredrickson, 2001), 
which highlights the effect of positive emotions in broadening intellectual, social 
and physical resources. The module contains the following techniques: 
- The importance of smiling. The week is divided into days when the patient has to smile 
as much as possible when interacting with other people and days when the patient has 
to act normally. The effects of “smiling days”/normal “no-smiling days” are discussed 
with the therapist in the following session.   
- Savoring. The patient is asked to engage in everyday activities that he/she normally 
does fast and without paying attention in a slower and more mindful manner (e.g., 
eating, taking a shower, walking or driving to work). The patient is then asked to think 
about how the slow, mindful way of doing these activities makes him/her feel 
compared to engaging in activities fast and unmindfully.   
- Daily time of enjoyment. The patient is encouraged to engage in some pleasant activity 
on a daily basis (e.g., drinking a cup of coffee or tea, doing sports, listening to music, 
going for a walk, having a conversation). The patient is also asked to think about how 
he/she felt during the activity and whether he/she would repeat it again, change it, or 
add something new to it.  
- Module 14: Learning to live. This module is divided into two sections. The first 
section is focused on the importance of identifying the individual’s own 
psychological strengths. The patients are shown the list of strengths proposed by 
Peterson & Seligman (2004) (e.g., curiosity, creativity, kindness, self-control, 
honesty, enthusiasm, equity, respect, gratitude) and asked to choose some of them 
and think about the ways to promote these strengths. The second section addresses 
the dimensions of wellbeing identified by Riff (1995, 2014) (e.g. purpose in life, 
autonomy, personal growth). This section includes an exercise to help the patient 
select and perform meaningful activities linked to personal values (e.g. for the 
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value “being a thoughtful friend”: “calling my friends once a week” /“catch up with 
a friend who I have not seen in a while”).  
- Module 15: Living and learning. One objective is to practice some exercises to 
promote emotions linked to wellbeing, such as gratitude (e.g., visit of gratitude, 
expressing gratitude) (Seligman, Steen, Park, & Peterson, 2005), hope (using an 
exercise based on the best possible self) (Sheldon & Lyubomirsky, 2006), and 
curiosity (encouraging the patient’s interest in different topics or activities). 
Another aim is to teach the patient to identify episodes of wellbeing and maintain 
them, using the strategy proposed by Fava (1999) in Well-being therapy, which 
consists of identifying thoughts and beliefs leading to the premature interruption of 
wellbeing. The patient is then asked to think about a more realistic way to interpret 
the situation in order to prolong the feelings of wellbeing as long as possible. 
 
Therapists and treatment fidelity 
The treatment protocols were administered by five different therapists working at the 
Emotional Disorders Clinic at Universitat Jaume I. All therapists but one delivered both 
protocols (TP and TP+PA). All of them were PhDs or PhD students with three to five years 
of experience in the diagnosis, psychological assessment and application of CBT for 
several ED. To ensure treatment fidelity, both therapists and patients were provided with 
detailed manualized treatment protocols for each of the modules. In addition, therapists 
they had been previously trained in the application of the treatment manuals, and they were 
supervised on a weekly basis by expert clinical psychologists, members of our research 
team who had been involved in the design and development of the treatment protocol.  
 
Statistical methods 
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All analyses were performed using the software SPSS version 22.0. Descriptive statistics 
(means and standard deviations) were calculated for all measures. Two-way repeated-
measures ANOVAs (time, treatment, treatment x time) were performed to explore the 
statistical significance of the differences within- and between- subjects on all measures. 
The magnitude of the intervention was expressed as Hedges’ g, a variation of Cohen's d 
(Cohen, 1988) that corrects for biases due to small sample sizes (Hedges & Olkin, 1985) 
and a recommended effect size estimator when sample sizes are lower than 20 (Hunter, & 
Schmidt, 2004). To interpret effect sizes, Cohen’s d convention (Cohen, 1988) was used, 
according to which an effect size of 0.20 is considered small, 0.50 is considered moderate, 
and 0.80 and above is considered large. Confidence intervals were also calculated for each 
of the effect sizes.  
Because the number of participants who dropped out from both groups is low (one 
participant in each condition), only completer analyses were performed.  	
Results 
 
Within and between-group changes in primary and secondary outcomes 
Means and standard deviations for both groups before and after the intervention and at the 
3-month follow-up are displayed in table 3.  
 
 
[Insert Table 3 about here] 
 
Within- and between-group effect sizes (Hedges’ g), as well as confidence 
intervals, are displayed in table 4. In general, within-group effect sizes were large to very 
large for the OASIS, the BDI-II, and the QLI in both treatment groups. Regarding the 
PANAS +, within-group effect sizes were mainly large in both groups, with overall larger 
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effect sizes in the TP+PA group than in the TP group at post-treatment and at the follow-
up.  However, the effect size for the TP group at post-treatment was in the moderate range 
(g = -.77). For the PANAS -, within-group effect sizes were all in the large range, with 
slightly larger effect sizes found in the TP+PA group than in the TP group at post-
treatment and at the follow-up. Regarding comparisons between conditions (between-
group effect sizes), a small effect size was observed at post-treatment and at the follow-up 
on all measures, including the PANAS +.  
 
[Insert Table 4 about here] 
 
To explore the statistical significance of the treatment gains and the differences 
between conditions, a two-way repeated-measures ANOVA was performed. The ANOVA 
showed a significant time effect on all measures: PANAS P (F(1.72,37.88) = 15.47, p <.001), 
PANAS N (F(1.54,33.85) = 44.13, p <.001) BDI-II (F(1.22,26.82) =49.84, p <.001) OASIS 
(F(1.72,37.91) =23.25, p <.001) and QLI (F(1.57,34.57) = 36.21, p <.001). The participants 
significantly improved from pre- to post-treatment on all outcomes, and these 
improvements were maintained at the 3-month follow-up. Nevertheless, the analysis failed 
to find a significant interaction effect (time x group) on any of the measures (p > .05). 
Thus, no significant differences were found between the two groups.  
 
Diagnostic status 
Results assessed by the MINI interview showed that 7 participants (58%) in the TP+PA 
condition and 8 in the TP condition (67%) no longer met the diagnostic criteria for any 
disorder at post-treatment. At the 3-month follow-up, 8 participants in the TP+PA 
condition no longer met the diagnostic criteria for any ED (67%), whereas 7 participants in 
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the TP condition (58%) no longer met these criteria. A chi-square test did not reveal any 
statistical difference in the proportion of diagnosis-free participants at post-treatment and 
at follow-up.  
 
Acceptability of the treatment 
Means and standard deviations for expectations and opinions about treatment are depicted 
in Table 6. In the TP+PA condition, results indicate that participants reported high scores 
on all the items measuring treatment expectations (scores between 7.83 and 8.58): logic of 
the treatment, satisfaction with the treatment, recommendation of the treatment to other 
people with similar problems, usefulness of the treatment for other psychological 
problems, and usefulness of the treatment for one’s specific problem. After receiving the 
intervention, scores for treatment opinions improved compared to scores for treatment 
expectations (scores between 8.08 and 8.83). Overall, the results for expectations and 
opinions in the TPP condition were higher than in the TPP+PA condition, ranging between 
8.83 and 9.17 for expectations, and between 8.58 and 9.67 for opinions. As indicated by a 
two-way repeated-measures ANOVA, no significant differences were found between the 
two groups on any of the items assessing expectations and opinions.  
 
[Insert Table 5 about here] 
 
Discussion 
The aim of the present study was to evaluate the feasibility, in terms of preliminary 
efficacy and acceptability, of a new transdiagnostic treatment protocol for ED that includes 
a specific therapeutic component to directly up-regulate PA. To do so, two versions of the 
same protocol were developed and tested in a randomized pilot study. One treatment 
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protocol includes strategies that focus on the regulation of NA alone (TP), and the other 
protocol adds these strategies to a treatment component to up-regulate PA (TP+PA). To the 
best of our knowledge, this is the first study to empirically investigate a transdiagnostic 
protocol for ED that integrates a specific component to directly up-regulate PA.  
One aim was to assess the effect of both interventions on a set of clinical measures. 
Overall, the analyses showed that both interventions resulted in significant improvements 
in all measures at post-treatment, and that the clinical gains were maintained at the 3-
month follow-up. Both interventions were effective in reducing depression and anxiety, 
and these gains were maintained at the follow-up assessment. Additionally, both treatment 
protocols led to significant improvements in quality of life at post-treatment and at the 3-
month follow-up. However, the analyses did not reveal any significant differences 
between-groups on any of the scales. 
We were also interested in studying the differential effects of the two interventions 
on PA. The first hypothesis was that the TP+PA would lead to significantly higher PA 
outcomes than the TP. The effect sizes for PA were larger in the TP+PA group than in the 
TP group at post-treatment (g = 1.34 versus g = .77) and at the 3-month follow-up (g = 
1.30 versus g = .85). Although not significant, these findings suggest that the inclusion of a 
treatment component to up-regulate positive affectivity might be important in enhancing 
PA outcomes. This component has already been empirically tested in a randomized 
controlled trial (RCT) exploring the efficacy of a web-based intervention for depression 
(Mira et al., 2017). As in the present study, this RCT examined an intervention that 
combined CBT techniques (i.e., psychoeducation about emotions, cognitive restructuring, 
behavioral activation) and PPIs, reporting significant improvements in NA and PA 
compared to a waitlist control group. Although there is a body of literature on PPIs, it is 
difficult to relate the results of this study to those of previous meta-analyses (e.g. Bolier et 
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al., 2013; Sin, & Lyubomirsky, 2009; Weiss et al., 2016) of these types of interventions, 
mainly because these meta-analyses utilized wellbeing as the outcome measure, rather than 
PA. Furthermore, the samples included in the aforementioned meta-analyses are rather 
heterogeneous, making the comparisons between this study and previous research on PPIs 
even more difficult. In any case, the treatment approach followed in the present work is 
consistent with recommendations about the importance of wellbeing and positive 
emotional functioning (Fava, 2016; Hasler, 2016) and the need for further research on 
these interventions.	Finally, although the main focus of this study was on PA, future 
research should study whether adding treatment components designed to up-regulate PA to 
transdiagnostic treatments for ED may result in better NA outcomes, compared to 
treatments where these components are absent. In any case, these results should be 
interpreted considering the pilot nature of this study.  
Regarding diagnostic status, the number of patients who met the diagnostic criteria 
for a principal disorder decreased at post-treatment, and this proportion was maintained at 
the 3-month-follow up.  There were no significant differences between groups in the 
number of participants who no longer met the diagnostic criteria for any disorder after the 
treatment, and these changes were maintained at the follow-up.  
Another objective was to explore the participants’ acceptability of the intervention. 
Results showed that participants in both groups had high expectations about the treatment 
protocol before receiving it. Moreover, after receiving the intervention, scores on their 
opinions improved compared to scores for treatment expectations. Attrition rate was low in 
both groups (one patient dropped out in each group), which also suggests the feasibility of 
this intervention for a sample of patients with ED. Taken together, the results support the 
acceptability of both interventions. Although the acceptability of the PA regulation 
component was not specifically assessed in this study, the results for adherence and 
 23		
acceptability are consistent with those found by Mira et al. (2017) for a web-based 
intervention for depression that also included the same component based on PPIs.  
In summary, these results suggest that both interventions were equally effective for 
the treatment of several ED. Moreover, acceptability did not differ significantly between 
conditions, suggesting that both interventions were similarly accepted by participants.  
The main strength of this study is the inclusion of a treatment component that 
directly addresses PA regulation (i.e. by increasing and maintaining PA). This protocol 
differs from other transdiagnostic treatments in that it addresses the regulation of positive 
affect in a more direct way, whereas other transdiagnostic treatments only integrate 
treatment strategies essentially aimed to down-regulate NA (e. g., Ellard et al., 2010; 
Norton, 2012, Titov, 2011, 2012).  
Previous research has proposed some directions to address both the assessment and 
treatment of PA regulation from a transdiagnostic perspective (e. g. Carl et al., 2013; Carl, 
Fairholme, Gallagher, Thompson-Hollands, & Barlow, 2014), but this field is quite new, 
and more research is needed on this topic. Questions remain about the specific contribution 
of treatment components aimed at PA regulation in transdiagnostic protocols: what the 
most effective strategies are; in what proportion; how and when each treatment component 
(regulation of PA and regulation of NA) should be present in transdiagnostic protocols; 
who this treatment approach might benefit the most (e. g. depression vs. anxiety disorders); 
and what the incremental effect of these strategies is on other relevant treatment outcomes 
such as anxious and depressive symptomatology and quality of life.  
This study has limitations that bear mention. First, it is a pilot study with a low 
number of participants and no waiting list control group. Second, the high effect sizes 
observed in this study must be interpreted in light of the non-significant confidence 
intervals shown at most measurement points. Third, this study does not allow us to 
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separate the effects of the NA- and PA-regulation components. Improvements in PA might 
be partly due to a carry-over effect, as participants underwent the PA-regulation sessions 
(sessions twelve to fifteen) after eleven sessions of NA regulation (sessions one to eleven), 
which makes it difficult to draw conclusions about the specific contribution of each of 
these treatment components. Fourth, although we assessed the effect of the intervention on 
both positive and negative affect, we did not include any measure focused on the 
underlying emotion regulation mechanisms that are hypothesized to be responsible for 
these changes. Five, most of the therapists involved in the study delivered both versions of 
the treatment (TP and TP+PA) and were not blind to the treatment conditions. Finally, the 
addition of a treatment component to one of the treatments tested in this study (TP+PA) 
resulted in a treatment with more sessions in one condition than in the other. For these 
reasons, future research should focus on exploring to what extent each of the different 
treatment components accounts for the improvement in measures of PA and NA and other 
clinical measures. One possible strategy to do so is conducting dismantling studies. Our 
research group is currently conducting a dismantling study in order to explore the specific 
contribution of different therapeutic components in the treatment of depression: a protocol 
that combines different components (i.e., CBT and PPIs), a protocol based on behavioral 
activation only, and a protocol based on PPIs only (the study protocol can be seen in 
https://clinicaltrials.gov/show/NCT03159715). 
In conclusion, this study represents an attempt to contribute to the existing gap in 
transdiagnostic treatments for emotional disorders by adding a treatment component that 
more directly addresses the regulation of PA. Preliminary efficacy and acceptability results 
indicate that both interventions are feasible to be tested in a larger RCT. Although we were 
unable to find a significant difference in PA due to the impact of the positive affect 
regulation component, the results found in this study suggest the potential impact that 
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including treatment components to directly target PA regulation may have on this 
temperament dimension. 
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Table 1. Description of participants at baseline   
TP+PA   TP 
      n  % n  % 
Gender         
 Female    8  67 11  92 
 Male    4  33 1  8 
Age 
 Mean (SD)    31.33 (12.48)  27.75 (10.91) 
 Range    21-61   18-57 
Education 
 Basic studies   3  25 1   8 
 Medium studies   7  58 4   33 
 Superior studies   2  17 7   58 
Marital status 
 Married/partnered   6  50 5   42 
 Single    6  50 6   50 
 Divorced/Widowed   0  0 1   8 
Principal diagnostic 
 Generalized anxiety disorder 5  42 6   50 
 Major depression disorder  2  17 2   17 
 Agoraphobia   2  17 1   8 
 Panic disorder   2  17 1   8 
 Social anxiety disorder  1  8 1   8 
 Dysthymic disorder   0  0 1   8 
Number of comorbid diagnoses 
 0     7  58 6   50 
 1     3  25 3   25
  
 2 or more    2  17 3   25 
Note. TP+PA: Transdiagnostic Protocol + Positive Affect regulation component; TP: Transdiagnostic 
Protocol. 
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Table 2. Differences between the TP and the UP  
TP  UP (Barlow et al., 2011) 
M1. Introduction to treatment 
M2. Motivation for change and goal setting 
 
M3. Understanding the role of emotions 
(psychoeducation about emotions and goal 
setting) 
Component 1: Present-focused emotional 
awareness 
M4. Non-judgmental emotional awareness 
and acceptance of emotional experiences  
M5. Practicing present-focused awareness: 
physical sensations, thoughts, emotions and 
daily activities  
 
Component 2: Cognitive Flexibility 
M6. Learning to be flexible (identification of 
thinking traps) 
M7. Practicing cognitive flexibility (cognitive 
reappraisal and evaluation of intrusive 
thoughts) 
 
Component 3: Emotion avoidance and 
emotion-driven behaviors 
M8. Emotional avoidance 
M9. Emotion-driven behaviors 
 
Components 4 and 5:  
Awareness and tolerance of physical 
sensations  
Interoceptive and situation-based emotion 
exposure 
M10. Accepting and facing physical 
sensations 
M11. Facing emotions in the contexts in 
which they occur 
 
 
M12: Relapse prevention 
 
Number of sessions: 12-18 
Session duration: 60 minutes 
M0. Introduction to treatment 
M1. Motivation engagement for treatment 
enhancement 
M2. Psychoeducation and tracking of 
emotional experiences 
 
Component 1: Present-focused emotional 
awareness 
M3. Emotion awareness training 
 
 
 
 
 
Component 2: Cognitive Flexibility 
M4. Cognitive Appraisal and Reappraisal 
 
 
 
 
 
Component 3: Emotion avoidance and 
emotion-driven behaviors 
M5. Emotion avoidance and emotion-driven 
behaviors 
 
Components 4 and 5:  
Awareness and tolerance of physical 
sensations  
Interoceptive and situation-based emotion 
exposure 
M6. Awareness and tolerance of physical 
sensations  
M7. Interoceptive and situation-based 
emotion exposures 
 
 
M8. Relapse prevention 
 
Number of sessions: maximum of 18  
Session duration: 50-60 minutes 
Note: A full description of the modules in the UP can be found in Barlow et al. (2011) 
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Note. Pre-T: Pre-treatment; Post-T: Post-treatment; F/U: 3-month follow-up. TP+PA: Transdiagnostic Protocol + Positive 
Affect regulation component; TP: Transdiagnostic Protocol; OASIS: Overall Anxiety Severity and Impairment Scale; BDI-
II: Beck Depression Inventory; PANAS +: Positive and Negative Affect Schedule – Positive Affect; PANAS -: Positive 
and Negative Affect Schedule – Negative Affect; QLI: Quality of Life Inventory 																				
Table 3. Descriptive statistics for all measures  
 TP+PA  TP 
 Pre-T Post-T F/U  Pre-T Post-T F/U 
 Mean (SD) Mean (SD) Mean (SD)  Mean (SD) Mean (SD) Mean (SD) 
OASIS 8.50 (3.99) 1.92 (2.43) 3.83 (5.04)  6.75 (3.79) 1.92 (2.11) 2.25 (1.82) 
BDI-II 20.33 (11.13) 3.08 (4.30) 4.92 (6.71)  15.58 (10.14) 2.58 (1.93) 2.75 (2.60) 
PANAS 
PA 
22.83 (7.72) 32.75 (7.11) 32.83 (7.66)  25.58 (7.51) 31.50 (7.82) 31.17 (5.54) 
PANAS 
NA 
29.83 (8.10) 14.67 (7.39) 15.92 (7.39)  25.25 (7.28) 14.67 (3.99) 15.67 (3.70) 
QLI 5.10 (1.46) 7.21 (1.11) 7.40 (1.22)  5.84 (1.27) 7.67 (.94) 7.65 (.80) 
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Table 4. Within- and between-group effect sizes for all measures 
 Within-group effect size, g  
[95% CI] 
 Between-group effect size, g 
[95% CI] 
 Pre-post  Pre-F/U  Post-T    F/U 
 TP+PA TP  TP+PA TP   
OASIS 1.99 
[.96, 2.89] 
1.57 
[.61, 2.43] 
 1.03 
[.14, 1.84] 
1.51 
[.56, 2.36] 
 .00 
[-.80, .80] 
.42 
[-.41, 1.21] 
BDI-II 2.04 
[1.00, 2.95] 
1.78  
[.78, 2.66] 
 1.66 
[.68, 2.52] 
1.73 
[.74, 2.60] 
 .15 
[-.66, .95] 
.43 
[-.40, 1.22] 
PANAS 
PA 
-1.34  
[-2.17, -0.41] 
-.77  
[-1.57, .08] 
 -1.30 
[-2.13, -.38] 
-.85 
[-1.65, .02] 
 .17 
[-.64, .96] 
.25 
[-.56, 1.04] 
PANAS 
NA 
1.96 
[.93, 2.85] 
1.80 
[.80, 2.68] 
 1.79 
[.79, 2.67] 
1.66 
[.93, 2.68] 
 .00 
[-.80, .80] 
.04  
[-.76, .84] 
QLI -1.63 
[-2.49, -.66] 
-1.64 
[-2.50, -.66] 
 -1.71 
[-2.58, -.72] 
-1.71 
[-2.57, -.72] 
 -.45 
[-1.24, .38]  
-.24 
[-1.04, .57] 
Note. Pre: Pre-treatment; Post: Post-treatment; F/U: 3-month follow-up. TP+PA: Transdiagnostic Protocol + Positive Affect 
regulation component; TP: Transdiagnostic Protocol; OASIS: Overall Anxiety Severity and Impairment Scale; BDI-II: Beck 
Depression Inventory; PANAS +: Positive and Negative Affect Schedule – Positive Affect; PANAS -: Positive and Negative 
Affect Schedule – Negative Affect; QLI: Quality of Life Inventory. Positive effect sizes denote a decrease in scores, negative 
effect sizes denote an increase. 						 																						
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Table 5. Means and standard deviations for expectations and opinion of treatment  
 TP+PA  TP 
 Expectations 
Mean (SD) 
Opinion 
Mean (SD) 
 Expectations 
Mean (SD) 
Opinion 
Mean (SD) 
Treatment is 
logical 
 
7.83 (1.80) 
 
8.25 (1.82) 
  
9.08 (.90) 
 
9.42 (.67) 
Satisfaction with 
the treatment 
 
8.08 (1.73) 
 
8.08 (2.23) 
  
9.08 (.79) 
 
9.50 (.67) 
Recommend to 
others 
 
8.58 (1.38) 
 
8.83 (1.80) 
  
9.00 (.95) 
 
9.67 (.65) 
Usefulness for 
other 
psychological 
problems 
 
 
7.75 (1.06) 
 
 
8.17 (1.70) 
  
 
8.83 (1.03) 
 
 
8.58 (.67) 
Usefulness for 
one’s specific 
problems 
 
7.83 (1.70) 
 
8.25 (1.66) 
  
9.17 (.94) 
 
9.42 (.79) 
Note. Scale ranges from 0 to 10, with higher scores indicating greater satisfaction. TP+PA: 
Transdiagnostic protocol + Positive affectivity regulation component; TP: Transdiagnostic 
protocol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	
